Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
12/03/2026
Palladium futures rose 1% intraday, now trading at $1,669.05 per ounce.
Latest
2 m ago
Failed sample delivery leads to a drop in stock price? Leontec Technology responds: We have never released any relevant information.
4 m ago
The German Institute for Economic Research (Ifo) stated that if energy prices remain high for a long period of time, the forecasted value of Germany's Gross Domestic Product (GDP) in 2026 may decrease by 0.2 percentage points.
4 m ago
The German Ifo Institute for Economic Research warns that long-term skyrocketing energy prices may lower the economic growth rate to 0.6% in 2026.
5 m ago
South Africa Statistics Bureau: South Africa's gold production in January decreased by 0.7% year-on-year.
6 m ago
Every AI express, Guojin Securities released a research report on March 12, giving Xintai (002294.SZ) a "buy" rating. The reasons for the rating mainly include: 1) Leading domestic heart and kidney metabolic syndrome, innovative transformation accelerating realization; 2) Nephrology, metabolism and orthopedic pipeline in full bloom, building a closed-loop chronic disease product; 3) Actively promoting the Hong Kong listing process, intending to empower innovative drug R&D through the construction of an "A+H" dual-capital platform. (Daily Economic News)
See all latest